
Doximity (DOCS) Stock Forecast & Price Target
Doximity (DOCS) Analyst Ratings
Bulls say
Doximity is a healthcare company with a positive outlook due to their increasing revenues and growing AI product usage, which will lead to a year of AI investment. Despite declining metrics, the company has reported record high engagement as doctors turn to their AI products, and they have also announced partnerships and product updates, positioning them for future growth. However, there are risks that could impede the stock, such as competition, M&A, and regulatory changes, as well as the potential for cybersecurity breaches or investments that could impact profitability.
Bears say
Doximity is facing challenges in the near-term due to market pressures, lower brand spend, and increased investments in AI. However, their adoption of AI could lead to positive outcomes in the second half of the fiscal year. While competition and potential budget limitations may impact their growth, VEEV is seen as a strong competitor in the healthcare industry.
This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.
Doximity (DOCS) Analyst Forecast & Price Prediction
Start investing in Doximity (DOCS)
Order type
Buy in
Order amount
Est. shares
0 shares